Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (29)
- Computing and Computational Sciences Directorate (39)
- Energy Science and Technology Directorate (229)
- Fusion and Fission Energy and Science Directorate (24)
- Information Technology Services Directorate (3)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (138)
- User Facilities (28)
- (-) Isotope Science and Enrichment Directorate (7)
Researcher
- Michael Kirka
- Rangasayee Kannan
- Ryan Dehoff
- Adam Stevens
- Christopher Ledford
- James Klett
- Mike Zach
- Peeyush Nandwana
- Alice Perrin
- Amir K Ziabari
- Andrew F May
- Annetta Burger
- Ben Garrison
- Beth L Armstrong
- Brad Johnson
- Brian Post
- Bruce Moyer
- Carter Christopher
- Chance C Brown
- Charlie Cook
- Christopher Hershey
- Corson Cramer
- Craig Blue
- Daniel Rasmussen
- Debjani Pal
- Debraj De
- Fred List III
- Gautam Malviya Thakur
- Hsin Wang
- James Gaboardi
- Jeffrey Einkauf
- Jennifer M Pyles
- Jesse McGaha
- John Lindahl
- Justin Griswold
- Keith Carver
- Kevin Sparks
- Kuntal De
- Laetitia H Delmau
- Liz McBride
- Luke Sadergaski
- Nedim Cinbiz
- Padhraic L Mulligan
- Patxi Fernandez-Zelaia
- Philip Bingham
- Richard Howard
- Roger G Miller
- Sandra Davern
- Sarah Graham
- Steve Bullock
- Sudarsanam Babu
- Thomas Butcher
- Todd Thomas
- Tony Beard
- Trevor Aguirre
- Venkatakrishnan Singanallur Vaidyanathan
- Vincent Paquit
- William Peter
- Xiuling Nie
- Yan-Ru Lin
- Ying Yang
- Yukinori Yamamoto

This technology aims to provide and integrated and oxidation resistant cladding or coating onto carbon-based composites in seconds.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

Simurgh revolutionizes industrial CT imaging with AI, enhancing speed and accuracy in nondestructive testing for complex parts, reducing costs.

An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence